Eastwood Historical Cash Flow

Stocks . Canada . 
Stock . Eastwood Bio Medical Canada
EBM Stock  CAD 0.75  0.05  6.25%   
Analysis of Eastwood Bio-Medical cash flow over time is an excellent tool to project Eastwood Bio Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Investments of 0.0 or Net Borrowings of 31.7 K as it is a great indicator of Eastwood Bio-Medical ability to facilitate future growth, repay debt on time or pay out dividends.
   Cash Flow   Balance Sheet   Income Statement
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Eastwood Bio Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Eastwood Bio Medical is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eastwood Bio Medical Canada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Eastwood Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Eastwood balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Eastwood's non-liquid assets can be easily converted into cash.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details

Eastwood Bio-Medical Cash Flow Chart

At this time, Eastwood Bio-Medical's Investments are fairly stable compared to the past year. Net Borrowings is likely to climb to about 31.7 K in 2024, despite the fact that Change In Cash is likely to grow to (18.3 K).
Sale Purchase Of Stock  Investments  Begin Period Cash Flow  End Period Cash Flow  Change To Liabilities  
Add Fundamental

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most accounts from Eastwood Bio-Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Eastwood Bio Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eastwood Bio Medical Canada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Eastwood Bio-Medical's Investments are fairly stable compared to the past year. Net Borrowings is likely to climb to about 31.7 K in 2024, despite the fact that Change In Cash is likely to grow to (18.3 K).

Eastwood Bio-Medical cash flow statement Correlations

Sale Purchase Of Stock
Change To Inventory
Investments
Change In Cash
Net Borrowings
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Non Cash Items
Capital Expenditures
Change To Account Receivables
Change To Operating Activities
Net Income
End Period Cash Flow
Change To Netincome
Change To Liabilities
Depreciation
Sale Purchase Of Stock
0.11-0.140.01-0.3-0.06-0.020.250.10.27-0.040.130.090.260.080.04-0.29
Change To Inventory
0.11-0.270.84-0.150.90.95-0.150.08-0.06-0.110.99-0.270.540.090.37-0.15
Investments
-0.14-0.27-0.610.46-0.38-0.180.640.070.54-0.06-0.18-0.470.150.06-0.780.31
Change In Cash
0.010.84-0.61-0.280.910.81-0.41-0.14-0.470.080.770.130.41-0.120.68-0.13
Net Borrowings
-0.3-0.150.46-0.28-0.24-0.07-0.210.250.27-0.03-0.17-0.61-0.430.220.030.69
Free Cash Flow
-0.060.9-0.380.91-0.240.93-0.33-0.19-0.340.10.870.040.42-0.160.37-0.05
Change In Working Capital
-0.020.95-0.180.81-0.070.93-0.2-0.11-0.130.080.95-0.290.47-0.10.290.02
Begin Period Cash Flow
0.25-0.150.64-0.41-0.21-0.33-0.20.10.61-0.16-0.05-0.160.660.1-0.62-0.43
Other Non Cash Items
0.10.080.07-0.140.25-0.19-0.110.10.43-0.70.04-0.49-0.010.990.06-0.18
Capital Expenditures
0.27-0.060.54-0.470.27-0.34-0.130.610.43-0.220.02-0.470.220.43-0.5-0.32
Change To Account Receivables
-0.04-0.11-0.060.08-0.030.10.08-0.16-0.7-0.22-0.10.24-0.1-0.72-0.020.24
Change To Operating Activities
0.130.99-0.180.77-0.170.870.95-0.050.040.02-0.1-0.310.580.050.25-0.17
Net Income
0.09-0.27-0.470.13-0.610.04-0.29-0.16-0.49-0.470.24-0.31-0.06-0.430.09-0.28
End Period Cash Flow
0.260.540.150.41-0.430.420.470.66-0.010.22-0.10.58-0.060.0-0.06-0.54
Change To Netincome
0.080.090.06-0.120.22-0.16-0.10.10.990.43-0.720.05-0.430.00.05-0.22
Change To Liabilities
0.040.37-0.780.680.030.370.29-0.620.06-0.5-0.020.250.09-0.060.050.01
Depreciation
-0.29-0.150.31-0.130.69-0.050.02-0.43-0.18-0.320.24-0.17-0.28-0.54-0.220.01
Click cells to compare fundamentals

Eastwood Bio-Medical Account Relationship Matchups

High Positive Relationship

Change To Operating Activities
+ 0.99
Change To Inventory
Change To Netincome
+ 0.99
Other Non Cash Items
Change In Working Capital
+ 0.95
Change To Inventory
Change To Operating Activities
+ 0.95
Change In Working Capital
Change In Working Capital
+ 0.93
Free Cash Flow
Free Cash Flow
+ 0.91
Change In Cash

High Negative Relationship

Change To Liabilities
- 0.78
Investments
Change To Netincome
- 0.72
Change To Account Receivables
Change To Account Receivables
- 0.7
Other Non Cash Items
Change To Liabilities
- 0.62
Begin Period Cash Flow
Net Income
- 0.61
Net Borrowings
Change In Cash
- 0.61
Investments

Eastwood Bio-Medical cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory107.5K(827.0)379.5K8.6K7.7K7.3K
Change In Cash(502.7K)(101.8K)19.0K(21.4K)(19.3K)(18.3K)
Free Cash Flow(542.7K)(121.8K)(7.3K)(16.9K)(15.2K)(16.0K)
Change In Working Capital183.7K393.9K34.1K417.6K375.9K267.6K
Begin Period Cash Flow625.4K122.7K20.9K39.8K35.9K34.1K
Other Cashflows From Financing Activities(23.1K)40K20K57.8K66.5K69.8K
Other Non Cash Items20.3K(11.9K)4.6K4.2K4.9K4.6K
Total Cash From Operating Activities(542.7K)(116.2K)(4.3K)(16.9K)(15.2K)(16.0K)
Change To Account Receivables69.3K3.7K(8.6K)124.0142.6149.73
Change To Operating Activities107.5K134.3K379.5K34.9K31.4K29.8K
Net Income(852.4K)(603.6K)(149.9K)(546.6K)(491.9K)(516.5K)
End Period Cash Flow122.7K20.9K39.8K18.4K16.6K15.8K
Change To Netincome97.4K(16.8K)(11.9K)4.6K5.3K5.1K
Change To Liabilities2.5K18.0K10.8K7.8K7.0K5.6K
Depreciation105.7K105.3K106.9K107.9K124.0K70.2K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Eastwood Stock Analysis

When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY